Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Effect of insulin therapy on plasma leptin and body weight in patients with type 2 diabetes.

Carey PE, Stewart MW, Ashworth L, Taylor R.

Horm Metab Res. 2003 Jun;35(6):372-6.

PMID:
12920661
2.

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.

Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, Fücker K, Julius U.

Acta Diabetol. 2002 Sep;39(3):105-10.

PMID:
12357293
3.
4.

Weight loss and leptin changes in individuals with type 2 diabetes.

Williams KV, Mullen M, Lang W, Considine RV, Wing RR.

Obes Res. 1999 Mar;7(2):155-63.

6.
7.

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

Metabolism. 2004 Nov;53(11):1454-61.

PMID:
15536601
8.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
9.

Relationship between plasma leptin and plasma insulin levels in type-2 diabetic patients before and after treatment with glibenclamide and glimepiride.

Bhattacharya SK, Madan M, Mahajan P, Paudel KR, Rauniar GP, Das BP, Roy RK.

Indian J Physiol Pharmacol. 2008 Jan-Mar;52(1):43-52.

PMID:
18831351
10.

[Reduced resistin levels in patients with type 2 diabetes mellitus].

Yang J, Li M, Wu CY, Wang H, Xu QS, Deng JY.

Zhonghua Yi Xue Za Zhi. 2003 Sep 10;83(17):1471-4. Chinese.

PMID:
14521723
12.

Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Yamano G, Yanagawa T, Ohgushi M, Ohya M, Yoshii S, Taki Y, Seino Y.

Metabolism. 2005 Mar;54(3):376-80.

PMID:
15736116
13.

Effect of exercise training on serum leptin levels in type 2 diabetic patients.

Ishii T, Yamakita T, Yamagami K, Yamamoto T, Miyamoto M, Kawasaki K, Hosoi M, Yoshioka K, Sato T, Tanaka S, Fujii S.

Metabolism. 2001 Oct;50(10):1136-40.

PMID:
11586483
14.

Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.

Kim HJ, Kim SK, Shim WS, Lee JH, Hur KY, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

Diabetes Res Clin Pract. 2008 Jul;81(1):42-9. doi: 10.1016/j.diabres.2008.02.001. Epub 2008 Apr 3.

PMID:
18394743
15.

The ratio of leptin to adiponectin can be used as an index of insulin resistance.

Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M.

Metabolism. 2008 Feb;57(2):268-73. doi: 10.1016/j.metabol.2007.09.011.

PMID:
18191059
16.

Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.

Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S.

Metabolism. 2005 Mar;54(3):281-6.

PMID:
15736103
17.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
18.

Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.

Komori T, Yoshida F, Nakamura J, Miyazaki S, Miura H, Iguchi A.

Exp Clin Endocrinol Diabetes. 2004 Sep;112(8):422-8.

PMID:
15372361
19.

Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus.

Al-Shoumer KA, Al-Asousi AA, Doi SA, Vasanthy BA.

Ann Saudi Med. 2008 Sep-Oct;28(5):367-70.

PMID:
18779635
20.

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.

Nar A, Gedik O.

Acta Diabetol. 2009 Jun;46(2):113-8. doi: 10.1007/s00592-008-0067-2. Epub 2008 Oct 7.

PMID:
18839053

Supplemental Content

Support Center